These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 49748)

  • 21. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.
    Klausner JM; Paterson IS; Kobzik L; Rodzen C; Valeri CR; Shepro D; Hechtman HB
    Ann Surg; 1989 Feb; 209(2):219-24. PubMed ID: 2644899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.
    Geyskes GG; Boer P; Vos J; Dorhout Mees EJ
    Lancet; 1976 May; 1(7968):1049-51. PubMed ID: 57453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Individual course of experimental acute renal failure: morphology, function, plasms renin activity (author's transl)].
    Held E; Schubert GE; Weber P; Zazkowski J
    Res Exp Med (Berl); 1974; 164(3):203-21. PubMed ID: 4453668
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine.
    Knight RJ; Collis MG; Yates MS; Bowmer CJ
    Br J Pharmacol; 1991 Dec; 104(4):1062-8. PubMed ID: 1810593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
    Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
    Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin and renin in glycerol-induced acute renal failure in the rat.
    Hofbauer KG; Konrads A; Bauereiss K; Möhring B; Möhring J; Gross F
    Circ Res; 1977 Oct; 41(4):424-8. PubMed ID: 902352
    [No Abstract]   [Full Text] [Related]  

  • 31. Propranolol protection in acute renal failure.
    Klein LA
    Invest Urol; 1978 Mar; 15(5):401-3. PubMed ID: 640802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.
    Efrati S; Berman S; Hamad RA; Siman-Tov Y; Ilgiyaev E; Maslyakov I; Weissgarten J
    Nephrol Dial Transplant; 2012 Jan; 27(1):136-45. PubMed ID: 21680852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin release and the refractoriness to acute renal failure of rats recovering from prior renal failure.
    Carvalho JS; Landwehr DM; Oken DE
    Nephron; 1978; 22(1-3):107-12. PubMed ID: 745630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
    Johannes T; Mik EG; Klingel K; Goedhart PT; Zanke C; Nohé B; Dieterich HJ; Unertl KE; Ince C
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):870-9. PubMed ID: 19413586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
    Joob AW; Harman PK; Kaiser DL; Kron IL
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):411-8. PubMed ID: 3005777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries.
    Helmchen U; Gröne HJ; Kirchertz EJ; Bader H; Bohle RM; Kneissler U; Khosla MC
    Kidney Int Suppl; 1982 Aug; 12():S198-205. PubMed ID: 6752536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
    Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
    Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.